Table 1 The overall statistical results from ANOVA evaluating differences in the amplitude and latencies of the visual cortex waveforms as resulting from the variables gene (WT and LRRK2-KO rats) and drug (vehicle and PFE360).
From: Knocking out the LRRK2 gene increases sensitivity to wavelength information in rats
Two-way ANOVA | ||||
|---|---|---|---|---|
F value | Adjusted p value (if p < 0.05) | |||
Amplitude of peaks in the visual cortex | ||||
P1 | Gene | F(1,27) | 13 | 0.0014 |
Drug | F(1,304) | 0.69 | ||
N1 | Gene | F(1,27) | 0.033 | |
Drug | F(1,304) | 0.88 | ||
P2 | Gene | F(1,27) | 0.65 | |
Drug | F(1,304) | 0.036 | ||
N2 | Gene | F(1,27) | 4.3 | 0.049 |
Drug | F(1,304) | 23 | 0.00021 | |
P3 | Gene | F(1,27) | 1.1 | |
Drug | F(1,304) | 33 | 0.00021 | |
N3 | Gene | F(1,27) | 64 | 0.00021 |
Drug | F(1,304) | 0.45 | ||
P4 | Gene | F(1,27) | 9.9 | 0.006 |
Drug | F(1,304) | 0.0079 | ||
Latency of peaks in the visual cortex | ||||
P1 | Gene | F(1,27) | 0.079 | |
Drug | F(1,304) | 16 | 0.00021 | |
N1 | Gene | F(1,27) | 16 | 0.00064 |
Drug | F(1,304) | 117 | 0.00021 | |
interaction | F(1,304) | 15 | 0.00036 | |
P2 | Gene | F(1,27) | 53 | 0.00021 |
Drug | F(1,304) | 54 | 0.00021 | |
N2 | Gene | F(1,27) | 0.80 | |
Drug | F(1,304) | 96 | 0.00021 | |
P3 | Gene | F(1,27) | 0.010 | |
Drug | F(1,304) | 69 | 0.00021 | |
N3 | Gene | F(1,27) | 15 | 0.0008 |
Drug | F(1,304) | 20 | 0.00021 | |
P4 | Gene | F(1,27) | 0.77 | |
Drug | F(1,304) | 10 | ||
